Editorial Commentary
Cognitive outcomes in prostate cancer treatment: insights from the ODENZA trial and future considerations
Translational Andrology and Urology
2025;
14
(4)
:864-867
.
(30 April 2025)
The patients have spoken: how does enfortumab vedotin impact quality of life?
Translational Andrology and Urology
2025;
14
(4)
:868-871
.
(30 April 2025)
Current perspectives of urine-based tests for screening and post-treatment monitoring of urothelial carcinoma of the bladder
Translational Andrology and Urology
2025;
14
(4)
:872-876
.
(30 April 2025)
Prophylactic mesh placement is not sufficient: what should we do to prevent parastomal hernia associated with ileal conduit?
Translational Andrology and Urology
2025;
14
(4)
:877-879
.
(30 April 2025)
Changes in the prostate biopsy landscape—how can we improve quality?
Translational Andrology and Urology
2025;
14
(4)
:880-882
.
(30 April 2025)
Choosing the path: insights into transperineal vs. transrectal prostate biopsy
Translational Andrology and Urology
2025;
14
(4)
:883-887
.
(30 April 2025)
Vibegron for overactive bladder in men with benign prostatic hyperplasia/obstruction: insights from the COURAGE trial
Translational Andrology and Urology
2025;
14
(4)
:888-892
.
(30 April 2025)
Gabapentin as an adjunct to multimodal pain management following scrotal surgery
Translational Andrology and Urology
2025;
14
(4)
:893-896
.
(30 April 2025)
Original Article
Piperlongumine inhibits renal cell carcinoma progression by modulating the DDX11-miR-15b-3p-DLD axis
Translational Andrology and Urology
2025;
14
(4)
:897-912
.
(30 April 2025)
Sexual wellbeing support for men with prostate cancer: a qualitative study with patients
Translational Andrology and Urology
2025;
14
(4)
:913-927
.
(30 April 2025)
Magnetic resonance imaging for computer-assisted device guidance in transperineal prostate biopsy and cryoablation
Translational Andrology and Urology
2025;
14
(4)
:928-939
.
(30 April 2025)
Novel anoikis-related genes for the diagnosis of non-obstructive azoospermia
Translational Andrology and Urology
2025;
14
(4)
:940-952
.
(30 April 2025)
Inverted V-shaped association between atherogenic index of plasma and kidney stone risk: results from NHANES 2011–2018
Translational Andrology and Urology
2025;
14
(4)
:953-963
.
(30 April 2025)
Causal role of immune cells in male infertility: a Mendelian randomization study
Translational Andrology and Urology
2025;
14
(4)
:964-973
.
(30 April 2025)
Regulator of cullins-1 predicts a poor prognosis and regulates epithelial-mesenchymal transition process through GSK-3β/Wnt signaling in renal cell carcinoma
Translational Andrology and Urology
2025;
14
(4)
:974-985
.
(30 April 2025)
Identification and validation of glycosyltransferase-related gene signatures to predict prognosis and immunological characteristics of renal clear cell carcinoma
Translational Andrology and Urology
2025;
14
(4)
:986-1004
.
(30 April 2025)
Establishment and clinical significance of genetic factor screening method for patients with nonobstructive azoospermia based on whole exon sequencing technology
Translational Andrology and Urology
2025;
14
(4)
:1005-1014
.
(30 April 2025)
Efficacy of microsurgical denervation of the spermatic cord in patients with chronic scrotal pain following unsuccessful varicocelectomy
Translational Andrology and Urology
2025;
14
(4)
:1015-1024
.
(30 April 2025)
Machine learning based on automated 3D radiomics features to classify prostate cancer in patients with prostate-specific antigen levels of 4–10 ng/mL
Translational Andrology and Urology
2025;
14
(4)
:1025-1035
.
(30 April 2025)
Three-dimensional measurement and analysis of the compressor urethrae and urethra in postpartum women
Translational Andrology and Urology
2025;
14
(4)
:1036-1048
.
(30 April 2025)
The disease burden of kidney cancer in Asian countries and regions from 1990 to 2021: a study based on the Global Burden of Disease database
Translational Andrology and Urology
2025;
14
(4)
:1049-1065
.
(30 April 2025)
Identification and validation of a 9-RBPs-related gene signature associated with prognosis and immune infiltration in bladder cancer based on bioinformatics analysis and machine learning
Translational Andrology and Urology
2025;
14
(4)
:1066-1081
.
(30 April 2025)
Development and validation of tryptophan metabolism-related risk model and molecular subtypes for predicting postoperative biochemical recurrence in prostate cancer
Translational Andrology and Urology
2025;
14
(4)
:1082-1110
.
(30 April 2025)
Extraperitoneal laparoscopic versus transperitoneal robot-assisted laparoscopic approaches during radical prostatectomy for low-risk or intermediate-risk prostate cancer
Translational Andrology and Urology
2025;
14
(4)
:1111-1118
.
(30 April 2025)
Real-world effectiveness of rezvilutamide plus androgen deprivation therapy in patients with low-volume, metastatic hormone-sensitive prostate cancer: a retrospective multicenter study
Translational Andrology and Urology
2025;
14
(4)
:1119-1128
.
(30 April 2025)
Brief Report
Penile cancer awareness and knowledge among adult patients in an ambulatory urology clinic
Translational Andrology and Urology
2025;
14
(4)
:1129-1137
.
(30 April 2025)
Case Report
Adenosquamous cell carcinoma of the penis: a case report and literature review
Translational Andrology and Urology
2025;
14
(4)
:1138-1146
.
(30 April 2025)
